← Leaderboards
Moiez Ali
Duke University
$194,884
Attributed
$194,884
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$194,884 · 1
By mechanism
F30$194,884 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Christopher M Counter$20,733,700
- Matthias Gromeier$11,871,021
- Christopher V Nicchitta$11,767,845
- Herbert I Hurwitz$4,193,162
- Kris C. Wood$5,294,947
Others in their field
Other Emerging Leaders on “Amino Acid Sequence”
- Alan James Bridge · European Molecular Biology Laboratory$8,871,376
- Chitra Upadhyay · Icahn School Of Medicine At Mount Sinai$5,213,150
- Rui Kong · Emory University$4,825,382
- Christian Harding · Vaxnewmo, Llc$4,584,476
- Alon Herschhorn · University Of Minnesota$4,348,325
- Norbert Pardi · University Of Pennsylvania$3,953,703
Research focus
Amino Acid SequenceAutomobile DrivingBaseBase SequenceBiochemicalCancer CellCell LineCellsCetuximabClinicCodon NucleotidesColorectal CancerCombined Modality TherapyCommunicationComplexDependenceDesignEctopic ExpressionEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorExperimental StudyGain Of FunctionGenetic ScreeningGold
Grant awards (4)
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance$46,300
F30 · FY2020 · CA · contact PI
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance$50,016
F30 · FY2019 · CA · contact PI
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance$49,524
F30 · FY2018 · CA · contact PI
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance$49,044
F30 · FY2017 · CA · contact PI